Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Avanos Medical Inc. (AVNS) Insider Trading Activity
Healthcare • Medical Devices • 3,771 employees
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Total Value
$0.00
Total Shares
114,204
Average Trade Value
$0.00
Most Active Insider
Blackford Gary
Total Activity: $0
Largest Single Transaction
$0
by Blackford Gary on Jan 2, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director
|
Jan 2, 2025 | 12,003 | $0 | 71,593 (+16.8%) | Grant | |
Director
|
Jan 2, 2025 | 12,003 | $0 | 25,814 (+46.5%) | Grant | |
Director
|
Jan 2, 2025 | 12,003 | $0 | 66,643 (+18.0%) | Grant | |
Director
|
Jan 2, 2025 | 12,003 | $0 | 16,820 (+71.4%) | Grant | |
Director
|
Jan 2, 2025 | 12,003 | $0 | 62,093 (+19.3%) | Grant | |
Interim CEO
Officer
|
Dec 3, 2024 | 10,000 | $0 | 200,898 (+5.0%) | Grant | |
Interim CEO
Officer
|
Oct 29, 2024 | 44,189 | $0 | 190,898 (+23.1%) | Grant |